Expression of constitutively active FOXO3 increased levels of cell death whereas a reduction in FOXO3 expression increased cell survival, providing evidence for FOXO3 playing a tumour suppressor role in CLL cells (103). This evidence concerns the gene FOXO3 and B-cell chronic lymphocytic leukemia.